Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer

被引：1
|
作者：
Dolinsky, CM
Mahmoud, NN
Mick, R
Sun, W
Whittington, RW
Solin, LJ
Haller, DG
Fry, RD
Metz, JM
机构：
[1] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2078
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [1] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [2] Improved rate of sphincter sparing surgery following preoperative chemoradiotherapy for rectal cancer with 5-FU/oxaliplatin (SFU/OX) compared to 5-fluorouracil (5-FU) alone
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R. W.
    Soling, L. J.
    Haller, D. G.
    O'Dwyer, P. J.
    Fry, R. D.
    Metz, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S281 - S281
  • [3] Evidence for improved pathologic complete response (PCR) rate after preoperative chemoradiotherapy with 5-FU/oxaliplatin (5FU/OX) for rectal cancer.
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R. W.
    Solin, L. J.
    Haller, D. G.
    Giantonio, B. J.
    O'Dwyer, P. J.
    Fry, R. D.
    Metz, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 162S - 162S
  • [4] THE USE OF 5-FLUOROURACIL (5-FU) IN STRABISMUS SURGERY
    CONNOLLY, WES
    KHAN, SJ
    DOLMESTCH, AM
    STOCKL, FA
    BURNIER, M
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S956 - S956
  • [5] 5-FLUOROURACIL (5-FU) PRESENTING AS A STEMI
    Okor, Ivana
    Ghosh, Priyanka
    Bhattarai, Shraddha
    Sattur, Sudhakar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3439 - 3439
  • [6] Photosensitivity due to 5-fluorouracil (5-FU)
    von Moos, R
    Sauter, C
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (1-2) : 52 - 52
  • [7] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) OR 5-FU PLUS METHYL-CCNU FOLLOWING SURGERY IN COLONIC CANCER
    DEXEUS, FA
    THIRLWELL, MP
    MACFARLANE, JK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 367 - 367
  • [8] Selective delivery of 5-fluorouracil (5-FU) to ip tissues using 5-FU microspheres in rats
    Hagiwara, A
    Sakakura, C
    Tsujimoto, H
    Imanishi, T
    Ohgaki, M
    Yamasaki, J
    Sawai, K
    Takahashi, T
    Fujita, T
    Yamamoto, A
    Muranishi, S
    Ikada, Y
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 182 - 188
  • [9] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    [J]. CANCER, 1972, 29 (05) : 1308 - +
  • [10] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
12345